Skip to main content

Table 13 EQ-5D-5L utility score estimates at baseline and follow-up

From: The multimorbidity collaborative medication review and decision making (MyComrade) study: a pilot cluster randomised trial in two healthcare systems

 

Intervention

N  =  59

Control

N  =  62

Intervention

N  =  59

Control

N  =  62

Intervention

N  =  59

Control

N  =  62

Health outcomes

Baseline, mean (SD)

4 months, mean (SD)

8 months, mean (SD)

EQ-5D-5L Score

0.67 (0.29)

0.52 (0.40)

0.66 (0.30)

0.58 (0.36)

0.70 (0.29)

0.56 (0.35)